Goldman Sachs Group Inc Dyne Therapeutics, Inc. Transaction History
Goldman Sachs Group Inc
- $555 Billion
- Q1 2024
A detailed history of Goldman Sachs Group Inc transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,661,088 shares of DYN stock, worth $53 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,661,088
Previous 1,160,772
43.1%
Holding current value
$53 Million
Previous $15.4 Million
205.47%
% of portfolio
0.01%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding DYN
# of Institutions
176Shares Held
87.1MCall Options Held
130KPut Options Held
209K-
Atlas Venture Life Science Advisors, LLC8.02MShares$256 Million28.49% of portfolio
-
Fcpm Iii Services B.V. Naarden, P77.85MShares$250 Million31.49% of portfolio
-
Black Rock Inc. New York, NY5.39MShares$172 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.56MShares$145 Million4.27% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.25MShares$136 Million0.02% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $1.65B
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...